Picture of SpectraCure AB (publ) logo

SPEC SpectraCure AB (publ) Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for SpectraCure AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-15.4-23.3-25.4-20.4-23
Non-Cash Items2.312.6833.562.61
Other Non-Cash Items
Changes in Working Capital3.692.06-0.578-1.8-1.43
Change in Accounts Receivable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-9.4-18.6-23-18.7-21.8
Capital Expenditures-10.6-8.49-10.1-15.8-15.3
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-1.230.2050
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-10.6-8.49-11.3-15.6-15.3
Financing Cash Flow Items-15.11.80
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities123-0.453-2.2-1.99-1.57
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash103-27.5-36.5-36.2-38.7